|
1
|
Zhang SW, Zheng RS, Yang ZX, Zeng HM, Sun
KX, Gu XY, Li H, Chen WQ and He J: Trend analysis on incidence and
age at diagnosis for lung cancer in cancer registration areas of
China, 2000-2014. Zhonghua Yu Fang Yi Xue Za Zhi. 52:579–585.
2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
2
|
Torre LA, Siegel RL and Jemal A: Lung
Cancer Statistics. Adv Exp Med Biol. 893:1–19. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang X and Guo Z: The role of sulfur in
platinum anticancer chemotherapy. Anticancer Agents Med Chem.
7:19–34. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kim J and Becker RC: Aspirin dosing
frequency in the primary and secondary prevention of cardiovascular
events. J Thromb Thrombolysis. 41:493–504. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Okada S, Morimoto T, Ogawa H, Sakuma M,
Matsumoto C, Soejima H, Nakayama M, Doi N, Jinnouchi H, Waki M, et
al: Effect of aspirin on cancer chemoprevention in Japanese
patients with type 2 diabetes: 10-Year observational follow-up of a
randomized controlled trial. Diabetes Care. 41:1757–1764.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hua H, Zhang H, Kong Q, Wang J and Jiang
Y: Complex roles of the old drug aspirin in cancer chemoprevention
and therapy. Med Res Rev. 39:114–145. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Di Francesco L, López Contreras LA, Sacco
A and Patrignani P: New insights into the mechanism of action of
aspirin in the prevention of colorectal neoplasia. Curr Pharm Des.
21:5116–5126. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Usman MW, Luo F, Cheng H, Zhao JJ and Liu
P: Chemopreventive effects of aspirin at a glance. Biochim Biophys
Acta. 1855:254–263. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yang G, Wang Y, Feng J, Liu Y, Wang T,
Zhao M, Ye L and Zhang X: Aspirin suppresses the abnormal lipid
metabolism in liver cancer cells via disrupting an NFκB-ACSL1
signaling. Biochem Biophys Res Commun. 486:827–832. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu J, Wei X, Wu Y, Wang Y, Qiu Y, Shi J,
Zhou H, Lu Z, Shao M, Yu L, et al: Giganteaside D induces
ROS-mediated apoptosis in human hepatocellular carcinoma cells
through the MAPK pathway. Cell Oncol (Dordr). 39:333–342.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liang Z, Chi YJ, Lin GQ, Luo SH, Jiang QY
and Chen YK: MiRNA-26a promotes angiogenesis in a rat model of
cerebral infarction via PI3K/AKT and MAPK/ERK pathway. Eur Rev Med
Pharmacol Sci. 22:3485–3492. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lei YY, Wang WJ, Mei JH and Wang CL:
Mitogen-activated protein kinase signal transduction in solid
tumors. Asian Pac J Cancer Prev. 15:8539–8548. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kim EK and Choi EJ: Compromised MAPK
signaling in human diseases: An update. Arch Toxicol. 89:867–882.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Geest CR and Coffer PJ: MAPK signaling
pathways in the regulation of hematopoiesis. J Leukoc Biol.
86:237–250. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu ZJ, Xiao M, Balint K, Smalley KS,
Brafford P, Qiu R, Pinnix CC, Li X and Herlyn M: Notch1 signaling
promotes primary melanoma progression by activating
mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt
pathways and up-regulating N-cadherin expression. Cancer Res.
66:4182–4190. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rehman SK, Li SH, Wyszomierski SL, Wang Q,
Li P, Sahin O, Xiao Y, Zhang S, Xiong Y, Yang J, et al: 14-3-3ζ
orchestrates mammary tumor onset and progression via
miR-221-mediated cell proliferation. Cancer Res. 74:363–373.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tibbles LA and Woodgett JR: The
stress-activated protein kinase pathways. Cell Mol Life Sci.
55:1230–1254. 1999.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ryu MJ and Chung HS: [10]-Gingerol induces
mitochondrial apoptosis through activation of MAPK pathway in
HCT116 human colon cancer cells. In Vitro Cell Dev Biol Anim.
51:92–101. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wu T, Ren MX, Chen GP, Jin ZM and Wang G:
Rrp15 affects cell cycle, proliferation, and apoptosis in NIH3T3
cells. FEBS Open Bio. 6:1085–1092. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Estaquier J, Vallette F, Vayssiere JL and
Mignotte B: The mitochondrial pathways of apoptosis. Adv Exp Med
Biol. 942:157–183. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ryu MJ, Kim AD, Kang KA, Chung HS, Kim HS,
Suh IS, Chang WY and Hyun JW: The green algae Ulva fasciata Delile
extract induces apoptotic cell death in human colon cancer cells.
In Vitro Cell Dev Biol Anim. 49:74–81. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Stadheim TA and Kucera GL: c-Jun
N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is
required for mitoxantrone- and anisomycin-induced apoptosis in
HL-60 cells. Leuk Res. 26:55–65. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sarbacker GB, Lusk KA, Flieller LA and Van
Liew JR: Aspirin use for the primary prevention of cardiovascular
disease in the elderly. Consult Pharm. 31:24–32. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pasche B, Wang M, Pennison M and Jimenez
H: Prevention and treatment of cancer with aspirin: Where do we
stand? Semin Oncol. 41:397–401. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Suvarna V, Singh V and Murahari M: Current
overview on the clinical update of Bcl-2 anti-apoptotic inhibitors
for cancer therapy. Eur J Pharmacol. 862(172655)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang X: The expanding role of mitochondria
in apoptosis. Genes Dev. 15:2922–2933. 2001.PubMed/NCBI
|
|
30
|
Peña-Blanco A and García-Sáez AJ: Bax, Bak
and beyond - mitochondrial performance in apoptosis. FEBS J.
285:416–431. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nagappan A, Park KI, Park HS, Kim JA, Hong
GE, Kang SR, Lee DH, Kim EH, Lee WS, Won CK, et al: Vitamin C
induces apoptosis in AGS cells by down-regulation of 14-3-3σ via a
mitochondrial dependent pathway. Food Chem. 135:1920–1928.
2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Leung HW, Yang WH, Lai MY, Lin CJ and Lee
HZ: Inhibition of 12-lipoxygenase during baicalein-induced human
lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol.
45:403–411. 2007.PubMed/NCBI View Article : Google Scholar
|
